Vstm stocktwits.

VSTM Stock. USD 0.52 0.06 10.29%. The current analyst and expert consensus on Verastem is Strong Buy, with 4 strong buy opinions. The current projected Verastem target price consensus is 1.26 with 0 analyst opinions. The most common way Verastem analysts use to provide recommendation to the public is financial statements analysis.A rating of 76 puts Verastem Inc near the top of the Biotechnology industry according to InvestorsObserver.Verastem Inc's score of 76 means it scores higher than 76% of stocks in the industry. Verastem Inc also received an overall rating of 54, putting it above 54% of all stocks.Find the latest Faraday Future Intelligent Electric Inc. (FFIE) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Verastem, Inc. (VSTM) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Verastem, Inc. Common Stock (VSTM) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets.

Adamis Pharmaceuticals Co. (NASDAQ:ADMP) posted its quarterly earnings data on Thursday, March, 31st. The specialty pharmaceutical company reported ($4.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.80) by $1.40.

øÿ@îU××ÓTóuÁË[ä@Èf Ì»?DÞØ ,qÒ – ¯è¯(º;Zû_(ôD‰&¡íÞ,r‚¸Þ ŸÝ Óoê ³ô3ÍKQÏb)=" ÇpÑw ”€èBwªÿ$t– nÌîUÏÎ Y±ê\ 2(À² ...Verastem, Inc.'s (NASDAQ:VSTM) stock rose 22% last week, but insiders who sold US$297k worth of stock over the last year are probably in a more advantageous position. Selling at an average price of US$1.70, which is higher than the current price, may have been the wisest decision for these insiders as their investment would have been worth less ...

Complete Verastem Inc. stock information by Barron's. View real-time VSTM stock price and news, along with industry-best analysis.NasdaqGM:VSTM Earnings and Revenue Growth September 26th 2022 It looks like hedge funds own 25% of Verastem shares. That's interesting, because hedge funds can be quite active and activist.5 analysts have issued 1 year price objectives for Verastem's shares. Their VSTM share price forecasts range from $21.00 to $39.00. On average, they predict the company's stock price to reach $31.00 in the next twelve months. This suggests a possible upside of 307.9% from the stock's current price. View analysts price targets for VSTM or view ...VSTM.US volatility (beta: 0.59) Avg. volatility (beta: 1.00) Low High. Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Verastem's is 0.5934. This would suggest that Verastem's shares are less volatile than average (for this exchange).

All groups and messages ... ...

Find the latest Earnings Report Date for Verastem, Inc. Common Stock (VSTM) at Nasdaq.com.

Verastem ( NASDAQ: VSTM) said it has entered into a collaboration deal with Chinese biotech GenFleet that allows it to license up to three drug candidates for commercialization outside of China ...By Karl Utermohlen, InvestorPlace Writer Dec 15, 2017. DDR (DDR) to spin off 50 properties, Hess (HES) to dethrone John Hess as CEO and Verastem (VSTM) announces $25 million common share offering.Verastem, Inc. (VSTM) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 8.06 +0.46 (+6.05%) At close: 04:00PM EDT The potential to reach targets may be lower with strong resistance areas.Verastem Oncology (NASDAQ: VSTM) is a biopharmaceutical company focused on exploring the unexplored to give patients diagnosed with cancer better options. Learn how VS-6766 and novel combinations may offer better control of the RAS and parallel pathways signaling to potentially expand the number of treatments for cancer patients.

This combo of drugs is a monster. I see 5-15.00 by Jan 2025. In addition to the progress with avutometinib + defactinib in LGSOC ONCT is moving two KRAS-G12C projects forward: avutometinib + sotorasib and avutometinib + adagrasib in KRAS- (G12C) NSCLC. Preclinical data suggests that we should see synergy with these combinations. Jul 5, 2023 · VSTM Stock Message Board for Investors. Verastem Inc. Stock Price, News and Company Updates. Message Board Total Posts: 49 VSTM Performance Breakdown Share Price The last publicly stated price for one share of an investment, updated every approximately 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).Curated by Yahoo Finance. Follow this list to discover and track penny stocks with the highest daily volume. The list includes stocks priced at $5 or less with a day change greater than 3%. This ...We would like to show you a description here but the site won’t allow us.After posting a net loss of $17 million in the second quarter, the company ended the first half of the year with just under $95 million of cash and marketable securities on its balance sheet ...Oct 9, 2023 · 2010. 57. Dan Paterson. https://www.verastem.com. Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase ...

VSTM Signals & Forecast. A buy signal was issued from a pivot bottom point on Wednesday, October 04, 2023, and so far it has risen 8.92%.Further rise is indicated until a new top pivot has been found. Verastem has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation.Featured Post From StockTwits About VSTM $VSTM am I the only dumbass that hasn’t blocked this tard here. Yeah, buyer @ $2, now $2.50, now $1.80.

Discover historical prices for VSTM stock on Yahoo Finance. View daily, weekly or monthly format back to when Verastem, Inc. stock was issued.Verastem press release (VSTM): Q1 Non-GAAP EPS of -$0.09.Verastem Oncology ended the first quarter of 2023 with cash, cash equivalents and investments of $111.2 million.Shares -4% AH.See Verastem, Inc. (VSTM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Ticker Owner Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4; NTNX: Wall Tyler: Chief Legal Officer: Oct 10: Sale: 36.87: 35,000: 1,290,300VSTM, $VSTM, Verastem Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicatorsIn a report released today, Mara Goldstein from Mizuho Securities maintained a Buy rating on Verastem ( VSTM - Research Report ), with a price target of $36.00. The company's shares closed ...

Find the latest Precision BioSciences, Inc. (DTIL) stock quote, history, news and other vital information to help you with your stock trading and investing.

Based on analysts offering 12 month price targets for VSTM in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00.

Verastem. 07/11/23 Truist. Verastem price target lowered to $39 from $60 at Truist. 07/03/23 RBC Capital. Verastem price target lowered to $34 from $36 at RBC Capital. 06/26/23 Cantor Fitzgerald. Verastem price target raised to $34 from $3 at Cantor Fitzgerald. 06/15/23 Mizuho.Verastem, Inc. is a late-stage development biopharmaceutical company. The Company’s pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase kinase (MEK) inhibition ...Shares of NASDAQ VSTM opened at $8.22 on Thursday. Verastem has a twelve month low of $3.47 and a twelve month high of $15.18. The company has a current ratio of 9.14, a quick ratio of 9.14 and a ...US92337C2035. Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered ...Find the latest press releases from Verastem, Inc. Common Stock (VSTM) at Nasdaq.com.Jan 30, 2023 · Verastem (VSTM) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ... Verastem, Inc. (VSTM.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Verastem, Inc. | Nasdaq: VSTM | Nasdaq.Get the latest Verastem, Inc. (VSTM) stock news and headlines to help you in your trading and investing decisions.Get The Stocktwits Daily Rip. This room is for long term investors in the small and mid-cap biotech space with a focus on VSTM. Track Jounce Therapeutics Inc (JNCE) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Track Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares (LABD) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Presents Avutometinib and Defactinib Combination Program Updates at the 5th Annual RAS-Targeted Drug Development Summit. BOSTON, September 28, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the presentation of scientific background and clinical trial updates on the avutometinib and ...Track Invesco QQQ Trust Series 1 (QQQ) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsInstagram:https://instagram. parkwhiz sofi stadiumpeloton sounds like rubbinglitter robot cycling light flashingsammy watkins net worth As of 12:12PM EDT. Market open. BOSTON, September 05, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today ...By Investing.com. • May 09, 2023. Investing.com - Verastem (NASDAQ: VSTM) reported first quarter EPS of $-0.090, worse than the analyst estimate of $-0.080. Revenue for the quarter came in at $0 ... hudson's playground texascost of 30x30 concrete slab Track Southwestern Energy Company (SWN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Verastem Oncology Announces Pricing of $85.0 Million Public Offering of Common Stock and Pre-Funded Warrants. BOSTON-- (BUSINESS WIRE)--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten pu... boscov's military discount Verastem Presents Avutometinib and Defactinib Combination Program Updates at the 5th Annual RAS-Targeted Drug Development Summit. BOSTON, September 28, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the presentation of scientific background and clinical trial updates on the avutometinib and ...Verastem, Inc. (VSTM) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 8.06 +0.46 (+6.05%) At close: 04:00PM EDT